Questions from power points Flashcards
What would be the effect of IV atropine (muscarinic antagonist) on resistance vessel tone?
A. Moderate increase in constrictor tone B. Slight increase in constrictor tone C. No effect on tone D. Slight vasodilatory action E. Moderate vasodilatory action
C
Which set of direct action / reflex compensatory response would you see following IV administration of phenylephrine?
Direct Effect Baroreceptor Reflex Action
A. Vasodilation Reflex bradycardia
B. Vasodilation Reflex tachycardia
C. Vasoconstriction Reflex bradycardia
D. Vasoconstriction Reflex tachycardia
C
In response to an acute decrease in blood pressure, what is the initial compensatory response?
A. Increased parasympathetic input to the SA node
B. Increased sympathetic input to the SA node
C. Increased release of aldosterone from the adrenal cortex
D. Increased angiotensin II in the bloodstream
B
Activation of the sympathetic nervous system in response (flight-or-fight response) to an environmental stressor causes epinephrine release from the adrenal gland, resulting in which of the following actions?
A. Decreased blood glucose levels
B. Bronchoconstriction
C. Pupil constriction (miosis)
D. Increase in AV node conduction velocity
E. Increased GI motility
F. Relaxation of peripheral resistance vessels
D
Which of the following autonomic nervous system drugs would be MOST likely to predispose a patient to cardiac arrhythmias due to an increase in cardiac conduction rate?
A. Albuterol B. Atenolol C. Isoproterenol D. Pilocarpine E. Propranolol
C
A concern when examining patients is the possibility that they may be taking medications that interfere with the function of the baroreceptor reflex and can increase the potential for orthostatic hypotension. This would be most likely to occur with which class of autonomic nervous system drugs?
A. Atropine B. Pilocarpine C. Neostigmine D. Doxazosin E. Albuterol
D
Which of the following statements concerning the ions and ion channels involved in the cardiac ion potential is FALSE?
A. “Trigger” Ca++ for cardiac muscle contraction moves into ventricular cells during phase 2 of the action potential.
B. Phase 0 current in ventricular muscle cells is carried by Na+ ions.
C. Phase 4 current in the SA node pacemaker cells is an important determinant of automaticity.
D. Repolarization (phase 3) in ventricular cells occurs when potassium channels close
D
As a calcium channel blocker, diltiazem (Cardizem®) would be categorized in which class of antiarrhythmic agents?
A. Class I B. Class II C. Class III D. Class IV E. Miscellaneous
D
A 58-year-old man had a myocardial infarction. Which of the following should be used to prevent life-threatening arrhythmias that can occur post-MI in this patient?
A. Flecainide B. Digoxin C. Metoprolol D. Lidocaine E. Amiodarone
C
The most common mechanism of arrhythmias, accounting for as many as 85% of all arrhythmias, is:
A. Failure of impulse initiation at SA node
B>. Failure of impulse conduction thru AV node
C. Enhanced automaticity at SA node
D. Triggered automaticity in ventricular tissue
E. Abnormal impulse conduction due to reentry phenomenon
E
Suppression of arrhythmias resulting from a reentry focus is most likely to occur if the drug:
A. Has vagomimetic properties on the AV node
B. Is a beta-blocker
C. Converts a unidirectional block to a bidirectional block
D. Slows conduction through the atria
E. Has atropine-like effects at the AV node
C
A 78-year-old woman has been newly diagnosed with atrial fibrillation. She is currently not having symptoms of fatigue or palpitations. Which drug is appropriate to initiate for rate control?
A. Amiodarone B. Metoprolol C. Sotalol D. Lidocaine E. Flecainide
B
Which of the following is correct regarding digoxin when used for atrial fibrillation?
A. Digoxin works by blocking voltage-sensitive calcium channels
B. Digoxin produces vagomimetic effects at the AV node
C. Digoxin is used for rhythm control in patients with atrial fibrillation
D. Digoxin increases conduction velocity through the AV node
B
The drugs most commonly used for rate control in patients with atrial fibrillation include:
A. Beta-blockers B. Verapamil C. Diltiazem D. Amlodipine E. All of the above
A, B and C
Which of the following beta-blockers is not available in an oral formulation?
A. Metoprolol
B. Propranolol
C. Esmolol
D. Carvedilol
C
Adverse effects of amiodarone include:
A. Bluish-gray skin discoloration B. Pulmonary fibrosis C. Hyperthyroidism D. Hyperthyroidism E. All of the above
E
The most effective drug available for maintenance of sinus rhythm in atrial fibrillation is:
A. Sotalol
B. Amiodarone
C. Diltiazem
D. Dronedarone
B
The treatment of choice for urgent conversion of atrial fibrillation to normal sinus rhythm is:
A. Anticoagulation
B. Catheter ablation
C. DC cardioversion
D. Digoxin
C
Lidocaine’s efficacy in the treatment of ventricular is related to which electrophysiologic action?
A. Block of L-type Ca++ channels at the AV node
B. Block of phase 3 K+ channels that mediate repolarization
C. Block of phase 0 Na+ channels that conduct impulses throughout the heart
D. Block of β1 receptors on cardiac muscle
E. Activation of purinergic receptors at the AV node
C
Lidocaine has the greatest efficacy in the treatment of which arrhythmia?
A. Torsades de pointes B. Ventricular fibrillation C. Atrial fibrillation D. Atrial flutter E. Ventricular tachycardia F Supraventricular tachycardia
E
Which drug is most likely to exacerbate heart failure?
A. Acetaminophen B. Naproxen C. Oxycodone D. Ibuprofen E. Amoxicillin F. Triazolam G. Nitrous oxide
B and D
A 68-year-old white man with heart failure with reduced ejection fraction being treated with enalapril and carvedilol comes to your office complaining of shortness of breath. On physical exam, he has bilateral rales and edema in both lower extremities. Which of the following would you recommend for acute relief of symptoms in this patient?
A. Combination of hydralazine and isosorbide dinitrate B. Valsartan C. Loop diuretic D. Thiazide diuretic E. Digoxin
C
Jake is a 75-year-old male who has heart failure. He is seen in your clinic today reporting shortness of breath, increased pitting edema, and a 5 pound weight gain. His current medication regimen includes lisinopril and metoprolol. He has no chest pain and is deemed stable for outpatient treatment. Which of the following is the best recommendation?
A. Increase the dose of lisinopril B. Add digoxin C. Start HCTZ D. Start furosemide E. Discontinue the metoprolol
D
A 59-year-old white man presents post-MI with heart failure symptoms and a LVEF of 29%. He is currently being treated with an ACE inhibitor and metoprolol succinate ER. Which of the following drugs has been shown to prolong survival in such a patient?
A. Digoxin
B. Eplerenone
C. Hydrochlorothiazide
D. Hydralazine and isosorbide dinitrate
B
Describe the beneficial effect of spironolactone in HF:
A. Promotes potassium excretion B. Promotes sodium retention C. Activates aldosterone receptors D. Blocks cardiac hypertrophy E. Decreases renin release
D
A male patient is placed on a new medication for heart failure and notes that his breasts have become tender to the touch. Which medication is he most likely taking?
A. Carvedilol B. Eplerenone C. Furosemide D. Hydrochlorothiazide E. Spironolactone F. Lisinopril
E
Beneficial actions of ACE inhibitors on the failing heart include:
A. Decreased adrenal release of aldosterone
B. Increased vascular resistance
C. Decreased cardiac output
D. Reduced preload
E. Reduced heart rate
F. Decreased cardiac remodeling action of angiotensin II
A, D and F
In patients with heart failure with reduced ejection fraction, ACE inhibitors have been shown to:
A. Improve symptoms
B. Decrease hospitalizations
C. Prolong survival
E. All of the above
D
The most common adverse effect of ACE inhibitors is:
A. Cough
B. Angioedema
C. Hypokalemia
D. Dizziness
A
Angiotensin receptor blockers (ARBs):
A. Are less effective than ACE inhibitors for treatment of chronic heart failure
B. Are more likely than ACE inhibitors to cause angioedema
C. Do not cause cough
D. All of the above
C
HC is a 70-year-old female who is diagnosed with HFrEF (reduced ejection fraction). Her past medical history is significant for hypertension and atrial fibrillation. She is taking furosemide, lisinopril, metoprolol, and warfarin. HC reports “feeling good” and has no shortness of breath or edema but she has been having fits of an annoying dry cough. Which is the most appropriate medication change to make at this time?
A. Discontinue furosemide B. Change lisinopril to losartan C. Decrease warfarin dose D. Add digoxin E. Add spironolactone
B
Inhibition of neprilysin decreases:
A. Vasoconstriction
B. Sodium retention
C. Maladaptive remodeling
D. All of the above
D
Entresto can cause:
A. Hypokalemia
B. Hypertension
C. Angioedema
D. All of the above
C
A 66-year-old man with asymptomatic (NYHA class I) heart failure with preserved ejection fraction (HFpEF) and cirrhosis asks if he should take Entresto for his heart failure. You could tell him that he cannot because:
A. His heart failure is asymptomatic
B. His ejection fraction is not reduced
C. Entresto is not recommended for patients with severe liver impairment
D. All of the above
B
Beta-blockers improve cardiac function in heart failure by:
A. Increasing heart rate B. Decreasing heart rate C. Increasing renin release D. Decreasing cardiac remodeling E. Reducing epinephrine release from the adrenal gland
D
Potential advantages of extended-release metoprolol succinate over carvedilol include:
A. Less hypotension
B. A lower risk of bronchospasm
C. Once-daily dosing
D. All of the above
D
Which of the following is correct regarding digoxin when used for atrial fibrillation?
A. Digoxin works by blocking voltage-sensitive calcium channels
B. Digoxin produces AV nodal blocking actions
C. Digoxin is used for rhythm control in patients with A Fib
D. Digoxin increases conduction velocity through the AV node
E. Digoxin levels needed for atrial fibrillation are higher than those necessary for symptom control in heart failure
B and A
In patients with heart failure, digoxin has been shown to:
A. Improve symptoms
B. Decrease hospitalizations
C. Prolong survival
D. All of the above
A and B
Which is most important to monitor in a patient taking digoxin?
A. Liver function B. Serum potassium C. Serum creatinine D. Serum calcium E. Troponin levels F Serum sodium
B
The mechanism of action of digoxin involves inhibition of Na+-K+-ATPase. This action ultimately leads to an increased force of cardiac contraction by increasing intracellular levels of which of the following ions?
A. Calcium B. Chloride C. Magnesium D. Potassium E. Sodium
A
Hypokalemia can occur with:
A. ACE inhibitors B. ARBs C. Aldosterone antagonists D. Digoxin – therapeutic levels E. Digoxin – overdose levels F. Loop diuretics
F
Drugs that relax vascular smooth muscle can produce a reflex tachycardia that can increase myocardial oxygen consumption and exacerbate symptoms in anginal patients. Which of the following anti-anginal agents are most likely to cause reflex tachycardia?
A. Diltiazem B. Metoprolol C. Nifedipine D. Nitroglycerin E. Verapamil
C and D
Which of the following anti-anginal agents can lower blood pressure?
A. Nifedipine B. Sublingual nitroglycerin C. Oral nitrates (e.g., isosorbide dinitrate) D. Metoprolol E. Verapamil F. Diltiazem
All of them
Stable angina:
A. Is periodic, short-lived episodes of severe substernal pain
B. Can be treated by pharmacologically decreasing cardiac preload
C. Is precipitated when an atherosclerotic plaque ruptures and occludes a coronary blood vessel
D. Occurs when O2 demand of some area of the myocardium exceeds the O2 supply to that area of heart muscle
E. Results from a paroxysmal spasm in a coronary vessel
A, B and D
All of the following drugs can be useful for managing stable angina in a patient with coronary artery disease EXCEPT:
A. Amlodipine B. Metoprolol C. Immediate-release nifedipine D. Isosorbide dinitrate E. Atenolol
C
If your patient has been prescribed a sustained-release oral nitrate preparation for prophylaxis of angina, you should be most alert for which of the following side effects?
A. Arrhythmias
B. Gastric upset
C. Gingival hyperplasia
D. Postural hypotension
D
A patient whose angina was previously well controlled with once-daily isosorbide mononitrate states that he recently has been taking it twice a day to control angina symptoms that are occurring more frequently during early morning hours. Which of the following is the best option for this patient?
A. Advise continuation of isosorbide mononitrate twice daily for full 24-hour coverage of anginal symptoms
B. Switch to isosorbide dinitrate daily as this has a longer duration of action than isosorbide mononitrate
C. Switch to NTG patch for consistent drug delivery and advise him to wear the patch around the clock
D. Continue once-daily administration of isosorbide mononitrate but advise the patient to take this medication in the evening
D
A 72-year-old male presents to the primary care clinic complaining of chest tightness and pressure that is increasing in severity and frequency. His current medications include atenolol, lisinopril, and prn sublingual nitroglycerin. Which intervention is most appropriate at this time?
A. Add amlodipine B. Replace atenolol with metoprolol C. Administer immediate-release nifedipine D. Initiate isosorbide dinitrate E. Chew 325 mg of aspirin and call 911
E
Which side effect is associated with amlodipine?
A. Bradycardia B. Cough C. Edema D. QT prolongation E. Hypotension F. Facial flushing
C, E, and F
Which of the following anti-anginal drugs does NOT act as a vasodilator and should not be used in the treatment of vasospastic angina?
A. Diltiazem B. Nifedipine C. Oral nitrates (isosorbide mononitrate) D. Metoprolol E. Verapamil
D
A 62-year-old patient with a history of asthma and vasospastic angina states that he gets chest pain both with exertion and at rest about 10 times a week. One sublingual NTG tablet always relieves his symptoms, but this medication gives him an “awful” headache every time he takes it. Which is the best option for improving his angina?
A. Change to prn sublingual NTG spray B. Add daily amlodipine C. Add daily metoprolol D. Add daily propranolol E. Replace prn NTG with ranolazine
B
Which of the following anti-anginal agents requires a drug free interval each day to lessen the development of tolerance to its antianginal actions?
A. Nifedipine B. Sublingual nitroglycerin C. Oral nitrates (e.g., isosorbide dinitrate) D. Transdermal nitroglycerin E. Metoprolol F. Verapamil
C and D
A 60-year-old white female has not reached her blood pressure goal after 3 months of treatment with a low dose of lisinopril. All of the following would be within recent guidelines for appropriate next steps in the treatment of her hypertension EXCEPT:
A. Increase dose of lisinopril B. Add a diuretic medication C. Add on a calcium channel blocker D. Add on an angiotensin receptor blocker E. Switch to an alpha-blocker
D and E
A 40-year-old male patient has recently been diagnosed with hypertension following readings of 163/102 and 165/100. He also has Type 2 diabetes that is well controlled with oral antidiabetic medications. Which is the best initial treatment regimen for management of hypertension in this patient?
A. Amlodipine and a beta-blocker B. Furosemide and lisinopril C. Lisinopril D. Lisinopril and hydrochlorothiazide E. Metoprolol
D
A patient returns to her physician assistant for routine monitoring 6 months after her hypertension regimen was modified. Lab results indicated an elevated potassium level. Which agents is most likely responsible for this hyperkalemia?
A. Lisinopril B. Chlorthalidone C. Hydrochlorothiazide D. Spironolactone E. Atenolol F. Furosemide G. Valsartan
A, D, and G
A patient with low blood levels of potassium (hypokalemia) would be at increased risk for toxicity from which of the following drugs?
A. Lisinopril (an ACE inhibitor) B. Digoxin C. Hydrochlorothiazide D. Propranolol E. Nifedipine
B